193 related articles for article (PubMed ID: 14965331)
1. Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease.
Murata M
Curr Pharm Des; 2004; 10(6):687-93. PubMed ID: 14965331
[TBL] [Abstract][Full Text] [Related]
2. Zonisamide has beneficial effects on Parkinson's disease patients.
Murata M; Horiuchi E; Kanazawa I
Neurosci Res; 2001 Dec; 41(4):397-9. PubMed ID: 11755227
[TBL] [Abstract][Full Text] [Related]
3. Zonisamide: a new drug for Parkinson's disease.
Murata M
Drugs Today (Barc); 2010 Apr; 46(4):251-8. PubMed ID: 20502722
[TBL] [Abstract][Full Text] [Related]
4. [The discovery of an antiparkinsonian drug, zonisamide].
Murata M
Rinsho Shinkeigaku; 2010 Feb; 50(2):67-73. PubMed ID: 20196486
[TBL] [Abstract][Full Text] [Related]
5. [Discovery of an antiparkinsonian drug: zonisamide].
Murata M
Rinsho Shinkeigaku; 2010 Nov; 50(11):780-2. PubMed ID: 21921440
[TBL] [Abstract][Full Text] [Related]
6. A novel anti-Parkinsonian agent, zonisamide, attenuates MPTP-induced neurotoxicity in mice.
Yano R; Yokoyama H; Kuroiwa H; Kato H; Araki T
J Mol Neurosci; 2009 Sep; 39(1-2):211-9. PubMed ID: 19199078
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of Parkinson's disease--up to date].
Murata M
Rinsho Shinkeigaku; 2008 Nov; 48(11):986-8. PubMed ID: 19198140
[TBL] [Abstract][Full Text] [Related]
8. Zonisamide: a review of the clinical and experimental evidence for its use in Parkinson's disease.
Grover ND; Limaye RP; Gokhale DV; Patil TR
Indian J Pharmacol; 2013; 45(6):547-55. PubMed ID: 24347760
[TBL] [Abstract][Full Text] [Related]
9. [Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases].
Janszky J
Ideggyogy Sz; 2009 Nov; 62(11-12):383-9. PubMed ID: 20025128
[TBL] [Abstract][Full Text] [Related]
10. Zonisamide suppresses endoplasmic reticulum stress-induced neuronal cell damage in vitro and in vivo.
Tsujii S; Ishisaka M; Shimazawa M; Hashizume T; Hara H
Eur J Pharmacol; 2015 Jan; 746():301-7. PubMed ID: 25261037
[TBL] [Abstract][Full Text] [Related]
11. Zonisamide for the treatment of Parkinson's disease.
Miwa H
Expert Rev Neurother; 2007 Sep; 7(9):1077-83. PubMed ID: 17868006
[TBL] [Abstract][Full Text] [Related]
12. Combination Therapy with Zonisamide and Antiparkinson Drugs for Parkinson's Disease: A Meta-Analysis.
Matsunaga S; Kishi T; Iwata N
J Alzheimers Dis; 2017; 56(4):1229-1239. PubMed ID: 28157097
[TBL] [Abstract][Full Text] [Related]
13. Zonisamide cotreatment delays striatal dopamine transporter reduction in Parkinson disease: A retrospective, observational cohort study.
Ikeda K; Yanagihashi M; Miura K; Ishikawa Y; Hirayama T; Takazawa T; Kano O; Kawabe K; Mizumura N; Iwasaki Y
J Neurol Sci; 2018 Aug; 391():5-9. PubMed ID: 30103971
[TBL] [Abstract][Full Text] [Related]
14. Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation.
Asanuma M; Miyazaki I; Diaz-Corrales FJ; Miyoshi K; Ogawa N; Murata M
Neurosci Res; 2008 Jan; 60(1):106-13. PubMed ID: 18022268
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of zonisamide target astrocyte.
Asanuma M; Miyazaki I; Diaz-Corrales FJ; Kimoto N; Kikkawa Y; Takeshima M; Miyoshi K; Murata M
Ann Neurol; 2010 Feb; 67(2):239-49. PubMed ID: 20225289
[TBL] [Abstract][Full Text] [Related]
16. Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.
Yamamura S; Ohoyama K; Nagase H; Okada M
Neuropharmacology; 2009 Sep; 57(3):322-31. PubMed ID: 19482038
[TBL] [Abstract][Full Text] [Related]
17. Zonisamide attenuates α-synuclein neurotoxicity by an aggregation-independent mechanism in a rat model of familial Parkinson's disease.
Arawaka S; Fukushima S; Sato H; Sasaki A; Koga K; Koyama S; Kato T
PLoS One; 2014; 9(2):e89076. PubMed ID: 24586512
[TBL] [Abstract][Full Text] [Related]
18. Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson's activity.
Gluck MR; Santana LA; Granson H; Yahr MD
J Neural Transm (Vienna); 2004 Jun; 111(6):713-24. PubMed ID: 15168218
[TBL] [Abstract][Full Text] [Related]
19. Zonisamide: aspects in neuroprotection.
Rösler TW; Arias-Carrión O; Höglinger GU
Exp Neurol; 2010 Aug; 224(2):336-9. PubMed ID: 20450911
[TBL] [Abstract][Full Text] [Related]
20. Zonisamide improves wearing-off in Parkinson's disease: A randomized, double-blind study.
Murata M; Hasegawa K; Kanazawa I; Fukasaka J; Kochi K; Shimazu R;
Mov Disord; 2015 Sep; 30(10):1343-50. PubMed ID: 26094993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
